[{"id":"e9a07c7f-e2d9-4292-868b-1159e1bb3343","acronym":"GO39869","url":"https://clinicaltrials.gov/study/NCT03451162","created_at":"2021-01-18T17:01:09.000Z","updated_at":"2024-07-02T16:36:18.140Z","phase":"Phase 1","brief_title":"Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer","source_id_and_acronym":"NCT03451162 - GO39869","lead_sponsor":"Genentech, Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e DHES0815A"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 04/17/2018","start_date":" 04/17/2018","primary_txt":" Primary completion: 07/16/2021","primary_completion_date":" 07/16/2021","study_txt":" Completion: 07/16/2021","study_completion_date":" 07/16/2021","last_update_posted":"2022-01-21"}]